Danaher Corporation (NYSE:DHR) is included among the 15 Best Low Volatility Blue Chip Stocks to Buy Now.
On April 6, Evercore ISI analyst Vijay Kumar lowered the firm’s price recommendation on Danaher Corporation (NYSE:DHR) to $225 from $254 and maintained an Outperform rating. The shares were also added to the firm’s “Tactical Outperform” list as part of its Q1 preview for medical technology and life science tools.
During the Q4 2025 earnings call, Rainer Blair, President, CEO, and Director, stated that the company reported sales of $24.6 billion, with core revenue rising 2%. He noted that the adjusted operating profit margin came in at 28.2%, while adjusted diluted earnings per share reached $7.80, reflecting a 4.5% increase. He also highlighted that the company generated $5.3 billion in free cash flow, which translated into a free cash flow to net income conversion ratio of about 145%.
Blair added that fourth-quarter sales totaled $6.8 billion, alongside core revenue growth of 2.5%. He further explained that, on a geographic basis, core revenues in developed markets saw low single-digit growth. North America remained largely flat, while Western Europe posted mid-single-digit gains.
Danaher Corporation (NYSE:DHR) operates as a global life sciences and diagnostics innovator. The company is organized across three segments: Biotechnology, Life Sciences, and Diagnostics.
While we acknowledge the potential of DHR as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 15 Cheapest Stocks with Highest Dividends and 15 Best Consistent Dividend Stocks to Buy Right Now
Disclosure: None. Follow Insider Monkey on Google News.
